Bangkok vaccinated against COVID-19 at Bang Khun Thian Elderly Hospital

general

01 March 2021 – 16:11

–

“Governor Knight” visits COVID-19 vaccination In the part of Bangkok at Bang Khun Thian Elderly Hospital Aiming to be able to inject as specified

Maj. Gen. Asawin Kwanmuang, Governor of Bangkok Visit to vaccination against COVID-19 To ensure the safety of the people At the hall, 1st floor, outpatient building Bang Khun Thian Elderly Hospital by Maj. Gen. Asawin revealed that today the Bangkok Metropolitan Administration has started vaccination against COVID-19. For medical personnel in Bangkok, totaling 130 hospitals, consisting of 30 Bang Khun Thian Elderly Hospital, 50 Hospital of Luang Pho Thaweesak Chutinatharo Uthit and 50 of Ratchapipat Hospital, totaling 130 including a number of private hospitals. 13 places to monitor If there are any unwanted symptoms, immediate care can be given.

Subsequently, the vaccination service will be offered to other target groups in the following week. Within this week, 3,700 medical personnel in six districts connected to Samut Sakhon Province will be inoculated for the second week. Related to the control of COVID-19 exposure to patients. For the third week, the vaccination will be given to 7 groups of chronic patients with high risk of disease.

The government has allocated a vaccine against COVID-19. The BMA, which is the SINOVAC vaccine company, 66,000 doses can be injected 33,000 cases, which will be completed around the third week of March 2021, then around the fourth week of the month the government will receive more vaccines. 800,000 doses in Bangkok will receive an additional 30% of the vaccine. To bring the injection service to personnel and the public

While Luang Pho Thaweesak Chutintaro Uthit Hospital, Nong Khaem district, has started vaccinating the SINOVAC brand of COVID-19 to medical personnel aged 18-59 years who have to get a total of 2 vaccines, with the second dose away from The first dose is 3 weeks.

For target groups, namely medical personnel Group of patients at risk age 18-59 years with chronic underlying disease. Patients over 60 years old are vaccinated with ASTRAZENECA.